ADIPOQ and type 2 diabetes mellitus: The current study was conducted to evaluate the potential modulatory impact of CANA and INDA on endogenous adiponectin and to pinpoint the molecular pathways of the anti-diabetic effects of both drugs via adiponectin modulation in a rat model of T2DM.